FluxMPS™ Leibovitz's L-15 Medium: 2X Liquid
FluxMPS™ DCP-LL152X is a Microfluidics Suitable, Quadruple-stage ultra-filtered Leibovitz's L-15 2X formulation engineered for primary cells and related cell models on organ-on-a-chip (OoC) and microphysiological system (MPS) platforms. A quadruple-stage train (0.1 µm ×2 + 0.04 µm ×2) reaches a 0.04 µm final cut-off, five times finer than the 0.22 µm membranes used for conventional sterile filtration. CO2-free by design — uses D-galactose and high amino-acid buffering for atmospheric pH maintenance.
- CO2-free by design: D-galactose energy source + high amino-acid buffering — no gas supplementation required
- Quadruple-stage filtration (0.1 µm ×2 + 0.04 µm ×2) reaching a 0.04 µm final polish for sub-mycoplasma-range purity
- Endotoxin release specification: < 0.05 EU/mL (LAL assay, USP <85>)
- Formulation: [+] 1.8 g/L D-Galactose, [+] L-Glutamine (600 mg/L), [+] Sodium Pyruvate (1100 mg/L), [+] Phenol Red — orange-red colored, clear solution
- Manufactured under an ISO 13485:2016 quality management system; final QC at Diagnocine, Totowa, NJ
- Amino-acid buffered to pH 7.4 — validated for atmospheric, CO2-independent culture
- 35 formulation components released per lot with full raw-material traceability
- Media familyLeibovitz's L-15 2X
- Formulation[+] L-Glutamine, [+] Phenol Red, [+] Calcium, [+] Magnesium, [+] Sodium Pyruvate, [-] Glucose
- Carbon sourceD-Galactose (1800 mg/L)
- AppearanceOrange-red colored, clear solution
- pH (USP <791>)7.4
- Osmolality (USP <785>)Contact for specification
- Endotoxin (USP <85>)< 0.05 EU/mL
- Filtration0.1 µm ×2 + 0.04 µm ×2 (Quadruple-stage)
- Storage2–8°C, away from light
- Shelf Life12 months from date of manufacture, unopened
Engineered where standard media fails
Conventional 0.22 µm–filtered Leibovitz's L-15 passes mycoplasma-sized particles and subvisible particulates that interfere with CO2-free pH maintenance and live-imaging clarity. FluxMPS™ is built to reduce these failure modes.
Microchannel-safe purity
0.04 µm final filtration and USP <788> Method 1 (light obscuration) particulate compliance support clear live imaging and CO2-free chip loading.
CO2-free by design formulation
Leibovitz's L-15 uses D-galactose (not glucose) as the primary carbon source, plus high amino-acid concentrations, for CO2-free pH buffering. This is a 2X concentrated formulation.
Ultrapure-grade water
Type 1 water (18.2 MΩ·cm) with controlled trace-metal and organic-carbon (TOC) content, minimizing contaminants that could affect formulation stability.
Low endotoxin release specification
< 0.05 EU/mL release specification — relevant where endotoxin-driven TLR4 activation could alter primary-cell phenotype.
CO2-independent design
D-galactose plus high amino-acid buffering is formulated to maintain pH under atmospheric conditions — no CO2 incubator required.
Customization on demand
pH, nutrient concentrations, HEPES, and component modifications available. Contact support@diagnocine.com.
Quadruple-stage filtration system
Four serial filtration stages — two paired prefilter + final-filter passes — reaching a final 0.04 µm polish.
-
1
0.1 µm Prefiltration I
Removes large particulate, cell debris and protein aggregates; protects the first 0.04 µm cartridge.
-
2
0.04 µm Final filtration I
First 0.04 µm pass; retains sub-micron particulates and microaggregates that pass a 0.22 µm filter, including mycoplasma-range particles (0.2–0.3 µm).
-
3
0.1 µm Prefiltration II
Second, dedicated prefilter protecting the second 0.04 µm cartridge.
-
4
0.04 µm Final filtration II — Polish
Ultimate polishing filter; aseptic fill in an ISO Class 5 (Class 100) environment.
Performance vs. conventional media
© Diagnocine® — DCP-LL152X
CO2-free live imaging and primary cell applications
FluxMPS™ DCP-LL152X — Leibovitz's L-15 2X — delivers 0.04 µm filtered purity for primary cells and related OoC applications.
Automated Bioreactors & Robotics
An optional 0.01 µm (10 nm) ultra nano-filtered MPS Grade variant is available on request for automated perfusion and robotics platforms.
- Total Particulate Exclusion: 0.01 µm filtration removes nanoparticulate aggregates
- Valve & Sensor Protection: Reduces micro-fouling risk in automated perfusion systems
- Extended Perfusion Stability: Consistent nutrient delivery over long-duration culture
Inquiry required: contact support@diagnocine.com for the 0.01 µm MPS Grade variant.
Open-Stage & CO2-Free Microscopy
L-15 plus galactose maintains pH without CO2 — a common base for prolonged live-cell confocal, TIRF, light-sheet, and spinning-disk imaging on open-stage microscopes.
Primary Cell Dissociation & Transport
CO2-free L-15 is commonly used as a dissociation and transport buffer for primary cells, tissue pieces, and organoids outside the incubator.
OoC Loading & Priming
CO2-independent L-15 enables chip loading, priming, and cell seeding outside incubators without pH drift during chip assembly.
In Vivo Imaging & Intravital Microscopy
L-15 is used as a superfusion medium for intravital microscopy, supporting pH maintenance in open tissue preparations without CO2 during surgical and imaging procedures.
CO2-Free Metabolic Studies
The galactose-based energy source supports metabolic studies without CO2 interference; galactose is commonly used to force oxidative phosphorylation in metabolically flexible cells.
Acute Brain Slice & Neuron Imaging
CO2-free L-15 supports neuronal viability in acute brain slice preparations and dissociated neuron imaging without carbogen (95% O2/5% CO2) gassing.
Analytical release specifications
Every lot released against the specification matrix below. CoA available on request: support@diagnocine.com.
| Parameter | Specification |
|---|---|
| Formulation | [+] L-Glutamine, [+] Phenol Red, [+] Calcium, [+] Magnesium, [+] Sodium Pyruvate, [-] Glucose |
| Appearance | Orange-red colored, clear solution |
| Carbon source | D-Galactose — 1800 mg/L (not glucose) |
| L-Glutamine | 600 mg/L |
| Sodium Pyruvate | 1100 mg/L |
| Phenol Red | 22 mg/L (phenol red sodium salt) |
| pH USP <791> | 7.4 |
| Osmolality USP <785> | Contact for specification |
| Total ingredients | 35 components across four composition groups |
| Parameter | Specification |
|---|---|
| Endotoxin USP <85> BET | < 0.05 EU/mL |
| Sterility USP <71> | No growth / 14 days |
| Mycoplasma | 0.1 µm mycoplasma-retentive filtration (not tested per lot) |
| Particulate ≥10 µm USP <788> Method 1 | NMT 25/mL |
| Particulate ≥25 µm USP <788> Method 1 | NMT 3/mL |
| Water purity | Type 1, 18.2 MΩ·cm |
| Manufacturing std. | ISO 13485:2016 |
| Fill environment | ISO Class 5 (Class 100) |
| Parameter | Specification |
|---|---|
| Storage temperature | 2–8°C, away from light |
| Freeze-thaw | Do not freeze |
| Shelf life | 12 months from date of manufacture, unopened |
| Shipping condition | Cold pack |
| CO2 requirement | CO2-independent by design — D-galactose and high amino-acid buffering maintain pH without gas supplementation |
| Parameter | Specification |
|---|---|
| Raw material grade | Reagent / cell culture grade |
| Traceability | Full lot traceability per ISO 13485 |
| Manufacturing QMS ISO | ISO 13485:2016 certified |
| UNSPSC | 41116155 — Molecular biology and cell culture growth media (UNv260801) |
| Regulatory alignment | 21 CFR Part 820 (QMSR) aligned |
| Production method | Micro-batch, per-lot QC release |
| Intended use | Research Use Only (RUO) |
Pack sizes available: 500 mL, 1000 mL.
Full composition (mg/L)
Leibovitz's L-15 2X: 35 components verified per lot with CAS numbers for raw-material traceability. L-15 uses D-galactose (not glucose) as the primary carbon source and high amino-acid concentrations for CO2-free pH buffering. This is a 2X concentrated formulation.
| Component | CAS Number | mg/L |
|---|---|---|
| INORGANIC SALTS | ||
| Calcium chloride dihydrate | 10035-04-8 | 370.000 |
| Magnesium chloride hexahydrate | 7791-18-6 | 400.000 |
| Magnesium sulfate anhydrous | 7487-88-9 | 195.440 |
| Potassium chloride | 7447-40-7 | 800.000 |
| Potassium phosphate monobasic | 7778-77-0 | 120.000 |
| Sodium chloride | 7647-14-5 | 16000.000 |
| Sodium dihydrogen phosphate anhydrous | 7558-80-7 | 380.240 |
| Component | CAS Number | mg/L |
|---|---|---|
| AMINO ACIDS | ||
| L-Alanine | 56-41-7 | 450.000 |
| Glycine | 56-40-6 | 400.000 |
| L-Arginine (free base) | 74-79-3 | 1000.000 |
| L-Asparagine | 70-47-3 | 500.000 |
| L-Cysteine (free base) | 52-90-4 | 240.000 |
| L-Glutamine | 56-85-9 | 600.000 |
| L-Histidine (free base) | 71-00-1 | 500.000 |
| L-Isoleucine | 73-32-5 | 500.000 |
| L-Leucine | 61-90-5 | 250.000 |
| L-Lysine hydrochloride | 657-27-2 | 188.000 |
| L-Methionine | 63-68-3 | 150.000 |
| L-Phenylalanine | 63-91-2 | 250.000 |
| L-Serine | 56-45-1 | 400.000 |
| L-Threonine | 72-19-5 | 600.000 |
| L-Tryptophan | 73-22-3 | 40.000 |
| L-Tyrosine disodium salt | 69847-45-6 | 552.320 |
| L-Valine | 72-18-4 | 200.000 |
| Component | CAS Number | mg/L |
|---|---|---|
| VITAMINS | ||
| Choline chloride | 67-48-1 | 2.000 |
| D-Ca-Pantothenate | 137-08-6 | 2.000 |
| Folic acid | 59-30-3 | 2.000 |
| Nicotinamide | 98-92-0 | 2.000 |
| Pyridoxine hydrochloride | 58-56-0 | 2.000 |
| Riboflavin-5-phosphate sodium salt | 130-40-5 | 0.200 |
| Thiamine hydrochloride | 67-03-8 | 2.000 |
| OTHERS | ||
| D-Galactose | 59-23-4 | 1800.000 |
| Sodium pyruvate | 113-24-6 | 1100.000 |
| Phenol red sodium salt | 34487-61-1 | 22.000 |
| i-Inositol | 87-89-8 | 4.000 |
Manufacturing & compliance
Every FluxMPS™ product is manufactured and released under a multi-layer quality system.
ISO 13485:2016 Quality Management
Manufactured under ISO 13485:2016-certified facilities. Final QA at Diagnocine R&D Center, Totowa, NJ, USA.
Ultrapure Type 1 Water
18.2 MΩ·cm, with controlled trace-metal and organic-carbon content.
ISO Class 5 Fill & Finish
Aseptic fill in validated ISO Class 5 (Class 100) laminar-flow workstations.
Micro-Batch Precision
Small-batch, per-lot tested — no blending; Certificate of Analysis available for every lot.
- Endotoxin — LAL assay, USP <85> Bacterial Endotoxins Test; assay sensitivity 0.005 EU/mL; release specification < 0.05 EU/mL
- pH, osmolality, conductivity, appearance and clarity
- Sterility
Endotoxin — USP <85> BET
LAL assay; release specification < 0.05 EU/mL per batch.
Particulate — USP <788> Method 1
Light obscuration count: NMT 25/mL (≥10 µm), NMT 3/mL (≥25 µm).
Osmolality — USP <785>
Target: Contact for specification.
Documentation & CoA
Full CoA with raw-material traceability available on request.
How DCP-LL152X compares
FluxMPS™ DCP-LL152X vs. conventional 0.22 µm–filtered Leibovitz's and standard formulations.
| Parameter | DCP-LL152X (FluxMPS™) | Conventional Leibovitz's L-15 (0.22 µm filtered) |
Standard DMEM/RPMI (0.22 µm filtered) |
|---|---|---|---|
| Grade | Microfluidics Suitable | Not specified | Not specified |
| CO2-free design (galactose-based) | check_circle Yes | check_circle Yes | cancel No |
| Final filtration pore size | 0.04 µm | 0.22 µm | 0.22 µm |
| Number of filtration stages | 4 (Quadruple) | 1 | 1 |
| Mycoplasma-retentive filtration | check_circle Yes (0.1/0.04 µm) | cancel No | cancel No |
| Endotoxin (release specification) | < 0.05 EU/mL | Corning classical liquid media — < 0.25 EU/mL Sigma-Aldrich DMEM complete medium — ≤ 2 EU/mL Gibco classical DMEM — Not specified (recorded per lot) |
|
| USP <788> particulate tested | check_circle Yes | cancel Not specified | cancel Not specified |
| Water quality | Type 1, 18.2 MΩ·cm | Not specified | Not specified |
| Manufacturing QMS | ISO 13485:2016 | Not specified | Not specified |
| Microfluidic channel compatibility | check_circle Microfluidics Suitable | cancel Risk of clogging | cancel Risk of clogging |
| Custom formulation available | check_circle Yes | Not specified | Not specified |
Comparison figures from published supplier specifications, accessed 2026-09-02. Suppliers that publish no numeric endotoxin specification are shown as "Not specified".
Frequently asked questions
Common questions about FluxMPS™ DCP-LL152X — Leibovitz's L-15 2X.
Supporting literature
Key publications relevant to Leibovitz's L-15 2X in CO2-free live-cell imaging, primary cell culture, and OoC applications.
- Leibovitz A. The growth and maintenance of tissue-cell cultures in free gas exchange with the atmosphere. Am J Hyg. 1963;78:173–180. doi:10.1093/oxfordjournals.aje.a120329
- Huh D, et al. Reconstituting organ-level lung functions on a chip. Science. 2010;328:1662–1668. doi:10.1126/science.1188302
- Bhatia SN, Ingber DE. Microfluidic organs-on-chips. Nat Biotechnol. 2014;32:760–772. doi:10.1038/nbt.2989
- Novak R, et al. Robotic fluidic coupling and interrogation of multiple vascularized organ chips. Nat Biomed Eng. 2020;4:407–420. doi:10.1038/s41551-019-0497-x
- Jang KJ, et al. Human kidney proximal tubule-on-a-chip. Integr Biol. 2013;5:1119–1129. doi:10.1039/c3ib40049b
- Schimek K, et al. Integrating biological vasculature into a multi-organ-chip microsystem. Lab Chip. 2013;13:3588–3598. doi:10.1039/c3lc50217a
- Luni C, et al. High-efficiency cellular reprogramming with microfluidics. Nat Methods. 2016;13:446–452. doi:10.1038/nmeth.3832
- Sung JH, et al. Microfabricated mammalian organ systems. Lab Chip. 2013;13:1201–1212. doi:10.1039/c3lc41017j
